Zobrazeno 1 - 10
of 38
pro vyhledávání: '"María José Ruiz-Hidalgo"'
Autor:
Elena Arconada-Luque, Jaime Jiménez-Suarez, Raquel Pascual-Serra, Syong Hyun Nam-Cha, Teresa Moline, Francisco J. Cimas, Germán Fliquete, Marta Ortega-Muelas, Olga Roche, Diego M. Fernández-Aroca, Raúl Muñoz Velasco, Natalia García-Flores, Cristina Garnés-García, Adrián Sánchez-Fdez, Sofía Matilla-Almazán, Víctor J. Sánchez-Arévalo Lobo, Javier Hernández-Losa, Borja Belandia, Atanasio Pandiella, Azucena Esparís-Ogando, Santiago Ramón y Cajal, Luis del Peso, Ricardo Sánchez-Prieto, María José Ruiz-Hidalgo
Publikováno v:
Scientia
Cancers; Volume 14; Issue 14; Pages: 3509
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Cancers; Volume 14; Issue 14; Pages: 3509
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Artículo escrito por un elevado número de autores, solo se referencian el que aparece en primer lugar y los autores pertenecientes a la UAM
Sarcomas are a heterogeneous group of tumors in which the role of ERK5 is poorly studied. To clarify th
Sarcomas are a heterogeneous group of tumors in which the role of ERK5 is poorly studied. To clarify th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a35f38ed936ede7163f04b5c3022011
https://hdl.handle.net/10486/705994
https://hdl.handle.net/10486/705994
Autor:
I. Andres, Sebastià Sabater, Marta Ortega-Muelas, Raquel Pascual-Serra, Ricardo Sánchez-Prieto, Elena Arconada-Luque, Borja Belandia, María José Ruiz-Hidalgo, Diego M. Fernández-Aroca, G. Bossi, Natalia García-Flores, Olga Roche
Publikováno v:
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
instname
[Background and purpose]: Gemcitabine is an antitumour agent currently used in the treatment of several types of cancer with known properties as a radiosensitizer. p38MAPK signalling pathway has been shown to be a major determinant in the cellular re
Autor:
Laura Arias-González, Inmaculada Moreno-Gimeno, Antonio Rubio del Campo, Serrano-Oviedo Leticia, María Llanos Valero, Azucena Esparís-Ogando, Miguel Ángel de la Cruz-Morcillo, Pedro Melgar-Rojas, Jesús García-Cano, Francisco José Cimas, María José Ruiz Hidalgo, Alfonso Prado, Juan Luis Callejas-Valera, Syong Hyun Nam-Cha, José Miguel Giménez-Bachs, Antonio S Salinas-Sánchez, Atanasio Pandiella, Luis del Peso, Ricardo Sánchez Prieto
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 15, Iss 6, Pp 649-659 (2013)
Extracellular signal-regulated kinase 5 (ERK5), also known as big mitogen-activated protein kinase (MAPK) 1, is implicated in a wide range of biologic processes, which include proliferation or vascularization. Here, we show that ERK5 is degraded thro
Externí odkaz:
https://doaj.org/article/7634b3ce804f4400989cd66c790679e9
Autor:
Natalia García-Flores, Jaime Jiménez-Suárez, Cristina Garnés-García, Diego M. Fernández-Aroca, Sebastia Sabater, Ignacio Andrés, Antonio Fernández-Aramburo, María José Ruiz-Hidalgo, Borja Belandia, Ricardo Sanchez-Prieto, Francisco J. Cimas
Publikováno v:
Cancers. 15:861
Over the last 30 years, the study of the cellular response to ionizing radiation (IR) has increased exponentially. Among the various signaling pathways affected by IR, p38 MAPK has been shown to be activated both in vitro and in vivo, with involvemen
Autor:
Francisco Ruiz-Marcos, Patricia González-Aguado, Borja Belandia, Olga Roche, Ana Serrano-Martínez, Juan-Ramón Romero-Macías, Ricardo Sánchez-Prieto, Raquel Pascual-Serra, María José Ruiz-Hidalgo
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Purpose]: Autophagy has lately emerged as an important biological process with implications in several hematological pathologies. Recently, a growing body of evidence supports a putative role of autophagy in chronic lymphocytic leukemia; however, no
Autor:
Raquel Pascual-Serra, Diego M. Fernández-Aroca, Elena Arconada-Luque, Marta Ortega-Muelas, Ismael Muñoz, Ricardo Sánchez-Prieto, Borja Belandia, Olga Roche, Isabel Sánchez-Pérez, María José Ruiz-Hidalgo, José Antonio Encinar, David Albandea‐Rodríguez
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of Cellular and Molecular Medicine
instname
Journal of Cellular and Molecular Medicine
© 2021 The Authors.
Sorafenib is a multikinase inhibitor widely used in cancer therapy with an antitumour effect related to biological processes as proliferation, migration or invasion, among others. Initially designed as a Raf inhibitor, Soraf
Sorafenib is a multikinase inhibitor widely used in cancer therapy with an antitumour effect related to biological processes as proliferation, migration or invasion, among others. Initially designed as a Raf inhibitor, Soraf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e75248a9af458ee13eae2f9c9c29e7a
http://hdl.handle.net/10261/265002
http://hdl.handle.net/10261/265002
Autor:
Olga Roche, Ricardo Sánchez-Prieto, Sebastià Sabater, María José Ruiz-Hidalgo, Raquel Pascual-Serra, Marta Ortega-Muelas, Diego M. Fernández-Aroca, Borja Belandia, I. Sánchez Pérez
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Targeting cell cycle has become one of the major challenges in cancer therapy, being Palbociclib, a CDK4/6 inhibitor, an excellent example. Recently, it has been reported that Palbociclib could be a novel radiosensitizer agent. In an attempt to clari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::899d0cb962250883724f993dcf163b5a
http://hdl.handle.net/10261/188896
http://hdl.handle.net/10261/188896
Autor:
Victoriano Baladrón, Laura López-Sanz, José J. García-Ramírez, María José Ruiz-Hidalgo, Jorge Laborda, Susana López-López, Eva M. Monsalve, Ángela Ballesteros, Almudena Ruiz-García, María José Díaz-Guerra
Publikováno v:
The Journal of Immunology. 197:3371-3381
The involvement of NOTCH signaling in macrophage activation by Toll receptors has been clearly established, but the factors and pathways controlling NOTCH signaling during this process have not been completely delineated yet. We have characterized th
Autor:
José J. García-Ramírez, Patricia García-Gallastegui, J Laborda, Maitane Aurrekoetxea, Victoriano Baladrón, María José Ruiz-Hidalgo, Jon Luzuriaga, Fernando Unda, Gaskon Ibarretxe
Publikováno v:
Cell and Tissue Research. 364:513-525
DLK1 (PREF1, pG2, or FA1) is a transmembrane and secreted protein containing epidermal growth factor-like repeats. Dlk1 expression is abundant in many tissues during embryonic and fetal development and is believed to play an important role in the reg
Autor:
Ricardo Sánchez-Prieto, Olga Roche, Elena Arconada-Luque, María José Ruiz-Hidalgo, Liliana F Mellor, Diego M. Fernández-Aroca, Natalia García-Flores
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 7524, p 7524 (2020)
International Journal of Molecular Sciences, Vol 21, Iss 7524, p 7524 (2020)
© 2020 by the authors.
The p38 mitogen-activated protein kinase (MAPK) signaling pathway is implicated in cancer biology and has been widely studied over the past two decades as a potential therapeutic target. Most of the biological and patholo
The p38 mitogen-activated protein kinase (MAPK) signaling pathway is implicated in cancer biology and has been widely studied over the past two decades as a potential therapeutic target. Most of the biological and patholo